Sabeen Sharif
Biographic Data
| ID | 3761597 |
|---|---|
| NAME | Sabeen Sharif |
| GIVEN NAMES | Sabeen |
| FAMILY NAME | Sharif |
| SIGNATURE | SHARIF S |
| AFFILIATIONS | Aga Khan University |
| ORCID | 0000-0002-3848-6443 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Incentivisation practices and their influence on physicians’ prescriptions
Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …
The healthcare field as a marketplace
Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…
No prominent works on this page.
Incentivisation practices and their influence on physicians’ prescriptions
Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …
The healthcare field as a marketplace
Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…
Business (2 works) · Economics (2 works) · Health care (2 works) · Healthcare cost, quality, practices (2 works) · Pharmaceutical Economics and Policy (2 works) · Pharmaceutical industry and healthcare (2 works) · Political science (2 works) · Public relations (2 works) · Sociology (2 works) · Economic growth (1 works)